ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EDEN Eden Research Plc

4.25
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.25 4.00 4.50 4.25 4.25 4.25 33,806 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.83M -2.24M -0.0042 -10.12 22.67M
Eden Research Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker EDEN. The last closing price for Eden Research was 4.25p. Over the last year, Eden Research shares have traded in a share price range of 3.20p to 12.00p.

Eden Research currently has 533,352,523 shares in issue. The market capitalisation of Eden Research is £22.67 million. Eden Research has a price to earnings ratio (PE ratio) of -10.12.

Eden Research Share Discussion Threads

Showing 10251 to 10271 of 17875 messages
Chat Pages: Latest  415  414  413  412  411  410  409  408  407  406  405  404  Older
DateSubjectAuthorDiscuss
30/6/2021
10:53
I couldn't have done... surely.
supersonico
30/6/2021
10:48
Did I miss the 'Expose'?
supersonico
30/6/2021
10:34
Say's everything positive that investors need to know!

From today's RNS

"Having dealt with the unique circumstances 2020 has presented us with, Eden has moved into fiscal 2021 well-funded and well positioned to achieve its mission to become a leader in biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries.

We have managed to manoeuvre our way through the global pandemic relatively unscathed and the future for Eden looks promising, with exciting developments in the pipeline.

The recently announced agreement with Corteva is, of course, significant to Eden and the seed treatment product area is an exciting addition to the already valuable, diverse portfolio of products and applications that the business has generated over the years."

investingisatrickygame
30/6/2021
10:28
Viva la 'Espose'
supersonico
30/6/2021
10:10
No Doubt the Scandi-Right Ones will be picking up some cheap shares in short Order.
supersonico
30/6/2021
09:44
lol keep your eyes on the share price

The slightly-less-stupid PIs (there are NO IIs!!) are jumping ship.

;D and rofl

neutralpov
30/6/2021
09:43
Nothing to be embarrassed about.

The AGM of this fukkery of a corp(se) is an irrelevance. Like a meeting of the Women's Rights division of the Taliban.

DISGUSTING!

neutralpov
30/6/2021
09:41
I am suitably embarrassed. Apologies.
ravenna23
30/6/2021
09:39
Ravenna:I don't know where you are living, but the AGM is this morning at noon as per RNS.
erinvale1
30/6/2021
09:37
Yesterdays announcement of an investor webinar today. I didn't read it properly. Sorry senior moment.
ravenna23
30/6/2021
09:34
What investor webinar yesterday?
swiftnick
30/6/2021
09:32
Apologies you are correct. I got mixed up with the investor webinar yesterday. The AGM is today.
ravenna23
30/6/2021
09:30
Get out when you can.

You will NEVER EVER recoup the results of your delaying your selling.

The next support level is the directors' own valuation of this pieceoshyte stock - i.e., SIX pence.

FFS, how stooopid can you be?

neutralpov
30/6/2021
09:30
No, they have not had the AGM. The AGM is at 12 noon today. The Virtual Investor Conference follows at 1:00pm.
swiftnick
30/6/2021
09:15
They have had the AGM, accounts were delayed until after the meeting due to COVID. Now you know the real reason. The directors were avoiding difficult questions. Shameful.
ravenna23
30/6/2021
09:09
Is anyone going to the meeting. The directors need to be called out for the annual reports' condescending nonsense and the company's lousy performance. I am inclined to agree with those who say that this company is dust.
erinvale1
30/6/2021
08:30
Don't get fooled by the market makers, big sells, e.g over NMS 50,000 will be delayed in reporting until later in the day when it will look as if they are buys. Shareholders have been duped by the CEO and CFO. They will have known about the FRC investigation for some time. It now appears their incentive scheme was set at a realistic price. 6p.
ravenna23
30/6/2021
08:10
The TerpeneTech mess is a poor reflection on the judgement of the company's auditors.
swiftnick
30/6/2021
07:42
On FRC watch list. Questionable creative accounting practices to increase reported revenue. Not good news. Add in poor results, Corteva deal is no more than another year of evaluation, increased overhead, and this is a bit of a stinker.
ravenna23
30/6/2021
07:30
Well posters here were always dubious about the Terpene Tech deal. Chickens have now come home to roost.
grahamg8
30/6/2021
06:08
Bill Gates
Co-chair, Bill & Melinda Gates Foundation
Seattle, Washington, United States Contact info

Bill & Melinda Gates Foundation

Harvard University
33,085,114 followers

33,072,145 - 33,085, 114 = -12969 / @21.36 = 33,093,125

GMS = +12969

supersonico
Chat Pages: Latest  415  414  413  412  411  410  409  408  407  406  405  404  Older

Your Recent History

Delayed Upgrade Clock